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Challenges in modeling complexity
of neglected tropical diseases: a review
of dynamics of visceral leishmaniasis in resource
limited settings
Swati DebRoy1, Olivia Prosper2, Austin Mishoe1 and Anuj Mubayi3*

Abstract
Objectives: Neglected tropical diseases (NTD), account for a large proportion of the global disease burden, and their
control faces several challenges including diminishing human and financial resources for those distressed from such
diseases. Visceral leishmaniasis (VL), the second-largest parasitic killer (after malaria) and an NTD affects poor populations and causes considerable cost to the affected individuals. Mathematical models can serve as a critical and costeffective tool for understanding VL dynamics, however, complex array of socio-economic factors affecting its dynamics need to be identified and appropriately incorporated within a dynamical modeling framework. This study reviews
literature on vector-borne diseases and collects challenges and successes related to the modeling of transmission
dynamics of VL. Possible ways of creating a comprehensive mathematical model is also discussed.
Methods: Published literature in three categories are reviewed: (i) identifying non-traditional but critical mechanisms
for VL transmission in resource limited regions, (ii) mathematical models used for dynamics of Leishmaniasis and other
related vector borne infectious diseases and (iii) examples of modeling that have the potential to capture identified
mechanisms of VL to study its dynamics.
Results: This review suggests that VL elimination have not been achieved yet because existing transmission dynamics models for VL fails to capture relevant local socio-economic risk factors. This study identifies critical risk factors of
VL and distribute them in six categories (atmosphere, access, availability, awareness, adherence, and accedence). The
study also suggests novel quantitative models, parts of it are borrowed from other non-neglected diseases, for incorporating these factors and using them to understand VL dynamics and evaluating control programs for achieving VL
elimination in a resource-limited environment.
Conclusions: Controlling VL is expensive for local communities in endemic countries where individuals remain in the
vicious cycle of disease and poverty. Smarter public investment in control programs would not only decrease the VL
disease burden but will also help to alleviate poverty. However, dynamical models are necessary to evaluate intervention strategies to formulate a cost-effective optimal policy for eradication of VL.
Keywords: Mathematical model, Dynamical modeling, Kala-azar, Leishmaniasis, Risk-factors
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Introduction
Visceral leishmaniasis (VL) is a vector-borne infectious
disease that is transmitted to humans by infected sandflies and is the second-largest parasitic killer in the world
after malaria [1, 2]. If left untreated, most cases result in
death within 2–3 years of clinical manifestation [3, 4].
In 2015, more than 90% of new cases of VL reported to
the World Health Organization (WHO) occurred in Brazil, Ethiopia, India, Kenya, Somalia, South Sudan, and
Sudan [2]. VL is identified as a Neglected Tropical Disease (NTD) by the WHO because it is endemic in several
poverty stricken regions of the world [5], although preventive measures and successful treatment is common
in most developed countries [6]. Many people living in
these impoverished regions are daily-wage workers, for
whom infection with a disease like VL restricts the breadwinners’ ability to provide livelihood for their families.
Moreover, the cost of treatment and duration of stunted
income pushes them into a vicious cycle of further hardship and irrecoverable financial deprivation. Although
local government authorities and the WHO have devised
several control programs (such as integrated vector management program and active surveillance) to lower the
burden of VL in these regions [7], the VL endemicity
always creeps back after a brief period of relief. This ineffectiveness has been attributed to several factors, including severe under-reporting of cases and death due to VL,
lack of clarity in the etiology of the disease (example, contribution asymptomatic infections have on transmission
is not known [8]), and limited estimation of reservoirs
of the infection (example, distribution of post-kala-azar
dermal leishmaniasis is unknown [9]). Thus, the intensity
and extent of the control programs have been in conflict with the magnitude of the true VL burden. In such
resource-limited regions mathematical models can help
shed light on respective contribution of several of these
challenges to the VL endemicity (including identifying
cost-effective driving mechanisms), as it has done for
other infectious diseases like malaria. Hence, immediate
attention from the modeling community is in dire need.
In the past, the WHO has set several elimination target dates for VL for years 2010 and 2015, which could not
be achieved in the Indian subcontinent [10]. The primary
reason for this shortcoming may be the ineffective implementation of policies in the under-developed regions
affected by VL. Mathematical modeling approaches in
conjunction with model guided additional field research
in India could be a turning point for achieving optimal
program implementation and may help to (1) quantify
the “true” burden of VL in Bihar where it has proven to
be particularly difficult to eliminate, (2) investigate the
potential mechanisms for the spread of the Leishmania
parasite, and (3) suggest optimal vector control programs
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that may help in achieving the WHO goal of elimination
of VL by the year 2017 [11]. The target of the VL elimination program is to reduce the annual incidence to less
than 1 per 10,000 at the district or sub district level in
South Asia by 2017 [12–14]. However, the incidence in
some parts may be around 20 cases per 10,000 [12, 14,
15].
Since Sir Ronald Ross’ first paper using a mathematical model to study the transmission dynamics of
malaria in 1906, there have been many modeling studies focusing primarily on vector-borne disease [16].
Existing studies of VL and other NTDs have been
either limited in their understanding of the transmission dynamics of the disease or fail to capture critical
local socio-economic factors. Hence, more studies are
needed on neglected tropical diseases such as VL, clarifying unknown aspects of etiology and modeling based
long term evaluation of dynamical interventions. Our
main objective in this study is to suggest mathematical
modeling approaches for capturing identified regional
issues that may be critical in better evaluating control
programs; thereby, developing optimal cost-effective
intervention strategy and timely achieving elimination
goals. We discuss specific features of VL (including
treatment availability, living conditions, effect of social
status, and implementation cost of control programs)
that should be incorporated into quantitative methods. We assessed the strengths and limitations of analytical models in addressing the risk factors and VBD
transmission. Finally, we provide recommendations for
future research on modeling VL dynamics and impact
of risk factors on VL transmission.

Methods
Search strategy

The following protocol was established for this review. We
searched Google Scholar, PubMed and Web of Knowledge to find articles focusing on “mathematical modeling
of vector-borne diseases” (VBD), “Visceral Leishmaniasis”,
“Kala-azar”, “risk factors of Leishmaniasis”, and “dynamics of Leishmaniasis”. The goal was to identify factors that
have been modeled and studied for understanding VL
dynamics and inform modeling strategies that needs to be
undertaken in order to systematically address challenges
for controlling (eventually eliminating) VL from resource
limited regions. For the theoretical literature, we included
epidemiological and public health studies that addressed
important technicalities of modeling the dynamics of vector borne infectious diseases, including, economic models, uncertainty and sensitivity analysis, and optimization
models. We also considered studies that evaluate impact
of socio-economic conditions on patterns of tropical
diseases.
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Selection criteria

Our search criterion was: articles that contain visceral
leishmaniasis (VL) AND VBD model AND risk factors
of VL. Our eligibility criteria were articles that: (i) were
published in peer reviewed journals and focused on
countries affected with neglected tropical diseases; (ii)
aimed to model risk factors for similar (to VL) vectorborne diseases; (iii) employed mechanistic models to
understand VL dynamics; and (iv) establish critical risk
factors from cross-sectional and longitudinal empirical VL (in South Asia) studies. A scheme of the selection
in outlined in a flowchart in the Additional file 1: Figure
S4. To identify data-supported risk factors, we reviewed
the literature based on searches using the term visceral
leishmaniasis with the subheading risk factors, and the
geographic terms India or Bangladesh or Nepal. Articles
published from 1985 through September, 2016 in English were included. We included all studies that explicitly addressed factors associated with risk of VL in South
Asia, the objectives, design, outcome measures and analyses were clearly described, and judged to be adequate
based on the methods and data presented. A formal comparison for studies on risk factors was impossible due to
scarce data from different time points, and non-comparable study designs and implications. We excluded studies
that did not incorporate disease transmission dynamics
such as studies with cost-effectiveness, and decision tree
type models. We also excluded opinion papers, review
articles, qualitative VL reports and modeling studies
comparing different regions. More details on how many
articles were retrieved by the search and how many were
excluded on each topic were given in first paragraph of
Results section.

Results
We collected 107 articles on topics mentioned in the
Search Strategy section (Additional file 1: Figure S4).
Among these 6 articles (out of 11 resulted from key-word
search)were on general epidemiological description of
family of leishmaniasis other than visceral leishmaniasis
and 3 articles (out of 7) were on other vector borne diseases not similar to VL. Hence, these articles were not
incorporated in the review. A total of 65 articles were
studied on risk factors of visceral leishmaniasis, however, 43 articles were eventually chosen for review based
on the consistent findings of risk factors within them
and our selection criteria. The risk factors in these 43
articles were grouped under six categories: Atmosphere
(20/31 articles were selected), Access (6/9), Availability
(4/7), Awareness (4/5), Adherence (7/10) and Accedence
(2/3). The 24 articles found in the databases are on the
dynamics of related (to Leishmaniasis) vector borne
diseases while 12 articles present interesting results on
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transmission dynamics of Leishmaniasis. Three additional articles on dynamics of Leishmaniasis were not
incorporated in the review as their primary goal was
mathematical analysis rather than implications for the
Leishmaniasis.
Identified VL risk factors: challenges for leishmaniasis
transmission dynamics in resource‑limited regions

The depth and complexity of the socio-economic challenges of a neglected tropical disease dynamics at the
grassroots level may seem disparate when considering them individually. Thus, to better comprehend the
nature of obstacles in the transmission process, we classified some of the key issues into the six categories viz.,
atmosphere, access, availability, awareness, adherence
and accedence (6 A-s). We note that these 6 As in turn
can be grouped into either inculcation or infrastructure
(2 I-s) (Fig. 1). Endemicity of VL in the region is fueled
by the deficiency in the 2 I-s, which in turn stems from
the sheer poverty in the affected area. Ultimately, it is
the poverty which cannot bear the cost of prevention,
and leads to a vicious cycle of VL dynamics there. In this
review we focus on the state of Bihar, which holds around
80% of India’s VL cases [17], and its neighboring countries of Nepal and Bangladesh where the disease dynamics are similar. We proceed to describe the relevance of
this 6 A-s. Some key features defining the 6 A-s are represented in Fig. 1.
Atmosphere

In the state of Bihar, the worst affected areas are in
remote agricultural villages. Studies have revealed several living conditions positively correlated with higher
prevalence of leishmaniasis. In two independent studies, factors like mud plastered houses, vegetation and
bamboo near the house, and granary inside the house
were found to significantly contribute to leishmaniasis
[18, 19]. Other systematic studies in the subcontinent
with similar geographical settings (Uttar Pradesh, India;
West Bengal, India; Terai, Nepal; Mymensingh, Bangladesh) have found that living conditions with cracked mud
walls, damp floors, and close proximity to a water body
are risk factors for leishmaniasis [20]. Also, a high density
of occupants in a household with more than three people per room were found to increase transmission [19,
21–28].
It is well known that sand-fly bites thrive during the
warmer months (March–June, October in India), and
late in the evening [29]. The role of climatic factors on
transmission dynamics of vector-borne diseases has been
thoroughly studied in the literature [30, 31]. The hot
Indian summer in combination with lack of electricity
often lead people to sleep outdoors, which increases the
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Fig. 1 A vicious cycle of socio-economic challenges and difficulty to access disease interventions

number of sand-fly bites and hence the risk of contracting leishmaniasis [23, 25]. Understandably, proper use of
bed-nets have been found to have a protective effect on
people across several studies, and sleeping on a cot (versus on the floor) also demonstrated a protective effect
as well [21, 23, 24, 26–28]. Proximity to domesticated
animals is found to play a complex role in containing,
spreading and serving as a possible reservoir of the parasite [32]. For example, some studies found that proximity
to livestock provided a protective effect against leishmaniasis as livestock get bitten more instead of humans [24,
25], whereas in Uttar Pradesh, India, the risk of leishmaniasis was found to increase with increased numbers of
cattle in the vicinity of a household because of large number of sandflies were attracted to cattle sites than to other
livestock sites [23].
Access

Currently, therapeutic interventions for Kala-azar (Indian
VL) are significantly subsidized by the Ministry of Health
in India (National Vector Bourne Disease Control Program’s Kala-azar Elimination Initiative under the Govt.
of India). In spite of the subsidize, estimates suggest that
80% of the outpatients and 57% of the inpatients are handled in the private sector (The World Bank report, 2001
[33]). Non-Government Organizations (NGOs) in Bihar
usually provide awareness and education programs, carryout research, and provide access to regular health services. Ninety percent of Bihar’s population lives in rural

areas where less than 1% of health services are provided
by not-for-profit NGOs (The World Bank, 2001 [33]).
Patients in rural areas travel on average much further for
treatment than patients in urban areas. Thus, access to
healthcare can be tricky at present and efforts need to be
made to encourage the set-up of temporary mobile clinics in harder to reach areas and to encourage people to
seek out certified treatment [3]. Bihar is the poorest state
in India, where the “caste” (proxy for social standing) of
a person is born into affects almost every aspect of the
social conduct he/she receives their entire life. [34] Martinez et al. found that the people of lower caste are consistently being seen by a doctor at a more advanced stage
of VL than those of a higher caste [35]. In fact, according
to the last article, most VL patients in the disadvantaged
caste see a doctor more than eight weeks post symptom
onset, which includes a larger spleen and lower hemoglobin level than normal. Thus, efforts need to focus
more on the people of lower caste to diminish the disparity in healthcare; only then can planned control measures
effectively reduce the overall burden of VL.
Availability

The WHO recommends the use of a single dose of
Amphotericin B as the first line of treatment in the Indian
sub-continent [36]. However, daily injections of Pentavalent Antimonials (SSG) for 20–30 days and 15 injections
of Amphotericin B every other day are still more widely
used in India (NVBDCP). The availability of drugs in a
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timely manner is dependent on several factors including
the affordability of a drug by the government, reasonable forecasting of the quantity of drug required (to avoid
shortage as well as waste), proper storage and distribution of the drugs throughout the lengthy route from the
manufacturer to the affected people, avoiding cheaper
counterfeit drugs and also drug legislation [37].
Awareness

‘Awareness’ can be defined as knowledge regarding the
etiology of the disease which would help local individuals
to prevent infection and to look out for VL symptoms and
seek medical attention sooner rather than later. Figure 2
shows some social aspects for which awareness programs
may be needed as a prevention for VL. Lack of awareness
causes a disease which is curable upon treatment, to end
up causing death. Even symptomatic VL-infected people
mix in the population freely, thus considerably increasing the chances of transmission. In a study on Nepal
(which shares a border with Bihar) by Rijal et al. [38] it
was found that affected people from the poorest strata of
the community preferred to visit a private doctor or local
faith healer over public health clinics, leading to lower
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short term cost but higher long term costs for these individuals because of inconsistent diagnosis and under par
treatment. Moreover, debts acquired during this period,
in addition to lack of income (the earning adult being ill),
creates a major financial abyss which is almost impossible to recover from. Thus, it is not sufficient that the government provides free treatment to the people, it is also
necessary to disseminate that information in an effective
manner to every strata of people in the affected region.
In a study in Brazil, awareness was spread in communities through educating school children, who in turn were
assigned to discuss interventions mentioned in student’s
homework assignments with their family members [39].
This intervention improved awareness significantly.
Adherence

Non-adherence to treatment is a major factor contributing to the high development of resistance to pentavalent antimonials in the population exposed to VL in the
Indian sub-continent [37]. This resulted in discontinuing it as a first line of treatment for VL. There are several
major factors which contribute to non-adherence in the
region including being male, older than 35 years of age,

Fig. 2 Cartoon reflecting social aspects on which awareness programs to control spread of VL can be designed to reduce disease burden
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lack of knowledge about the consequences of incomplete
treatment leading to patients stopping treatment once
the symptoms are relieved, and the financial loss due to
reduced days of productivity while on therapy [40, 41]. It
has been well documented in a 2000–2010 cohort study
in Nepal that another disease, Post Kala-azar Dermal
Leishmaniasis (PKDL), a sequel and reservoir for VL, was
more common in patients who were inadequately treated
during VL versus the ones who adhered to the full course
of treatment. A 29.4% PKDL prevalence was observed
in patients who were inadequately treated for VL with
sodium stibogluconate (SSG) versus 2.0% PKDL prevalence in VL patients who completed the full SSG course
[42]. As observed by Rijal et al. [38] loss of productivity implies no income at all for the poor families. Farmers are unable to attend to their fields, possibly during
very important farming phases which results in lowered
income for a considerable period of time. A lot of people
in the poorest section of society in Bihar are also dailywage earners and each missed day of work might present
dire consequences for the entire family. To survive this
period, the family takes out loans from private lenders at
high interest, ultimately leading them to further poverty.
Accedence

‘Accedence’ is defined as the acceptance to undergo testing and treatment for PKDL, which can occur in patients
who have recovered from VL post-treatment caused by
the same pathogen. As reported by Desjeux et al. in 2013,
patients with PKDL serve as a reservoir of VL and it is
unlikely that VL can be eradicated without addressing
the issue of diagnosing and treating PKDL [43]. In fact,
aggressive measures are required to encourage people to
consult a doctor in case of any persistent skin lesions, and
once diagnosed these should be treated with Amphotericin B, which has been found effective in the Indian
sub-continent. As reported by Thakur et al., attempts
were made to fast-track diagnosis and treatment of PKDL
in several badly affected districts of Bihar and yielded a
very positive outcome [44]. However, these efforts need
the support of the local governmental authorities to continue and succeed where it is most needed. It is evident
that aggressive control measures are necessary to address
every issue and to ultimately alleviate the burden of VL
from Bihar. However, several of the issues arise from limited resources in the affected region and thus the control
strategies should be carefully weighed by importance and
cost-effectiveness [45]. Moreover, it is not only important
to take drastic measures using the one-time funds generated for this purpose, but it is essential that powerful and
sustainable changes in the system are established through
easy and systematic ways of approaching the difficulties, which can only be attained by identifying critical
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mechanisms of the system. Mathematical models are one
of the best methods to cheaply and systematically identify driving factors.
Review of leishmaniasis dynamical modeling studies

Despite the incalculable harm and countless challenges
leishmaniasis inflicts on populations around the globe,
only a handful of publications address the problems from
a mathematical modeling perspective. In fact, a recent
review by Rock et al., which tabulates all mathematical models of VL, found only twenty-four articles using
mathematical models for VL, several of which used the
same base model structure [46]. Of these twenty-four
articles, only seven addressed VL in the Indian subcontinent. Arguably, one of the greatest modeling challenges is the limited understanding of the leishmania
pathogen, the sandfly vector, and how disease manifests
in humans. Dye et al. [47] spear-headed the application
of mathematical models to leishmania dynamics. The
authors developed a simple discrete-time model with
Susceptible, Infected, and Resistant humans to study the
mechanism behind inter-epidemic periods observed in
VL cases between 1875 and 1950 in Assam, India. Counter to the existing theory of the time, the model demonstrated that the observed inter-epidemic patterns could
be explained by intrinsic factors in leishmania transmission. This modeling effort also stressed the significance of
PKDL and sub-clinical infections in determining whether
a region will have endemic or epidemic leishmaniasis.
A few years later, Hasibeder et al. [48] published a compartmental delay-differential equation model for canine
leishmaniasis. This model accounts for two types of dogs:
those that will develop symptoms, and those that will
remain asymptomatic, following infection by a sandfly.
The model also explicitly describes the infection dynamics of the sandfly vector and considers a fixed delay representing the extrinsic incubation period. The authors
take a heuristic approach to derive a formula for the basic
reproduction number R0, the number of secondary sandfly infections resulting from a single infected sandfly, in
an otherwise fully susceptible population. Although this
model addresses two important aspects of the natural
history of the disease that may be extended to human
VL, namely the asymptomatic human and infected vector populations, the model does not consider the asymptomatic population to be an infectious reservoir, assumes
constant human and vector population sizes, and omits
the effects of seasonality. The model does, however,
introduce heterogeneous biting, determined by a dog’s
“occupation”. The mathematics developed in [48] was
applied to age-structured serological data for the dog
population in Gozo, Malta in [49], and provided estimates for R0. This modeling work was extended in [50]
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to include zoonotic transmission, that is, humans, dogs,
and sandflies, were explicitly modeled. Dye conducted a
sensitivity analysis to determine which of three control
measures would be most effective in decreasing disease
prevalence. Their results suggest vector control and vaccination of the human or dog population would be more
effective than treating or killing infected dogs. However,
in their model, they assumed that any treatment of dogs
results in full recovery and the efficacy of vaccination is
extremely high. These assumptions may not be completely realistic.
More recently, Stauch et al. developed a more comprehensive model of VL for the Indian subcontinent [51],
and later extended it to include drug-resistant and drug
sensitive L. donovani parasites, with a focus on Bihar,
India [52]. The model proposed by Stauch et al. [51]
extended the basic susceptible-infectious-recovered (SIR)
model structure for the human population by segmenting
the infected stage into five distinct stages according to an
individual’s infection status determined by the results of
three diagnostic markers. These diagnostic markers were
(1) PCR, the earliest infection marker, (2) DAT, which
measures antibody response, and (3) LST, which can
detect cellular immunity. The model also includes treatment of symptomatic VL cases, treatment failure, relapse
characterized as PKDL, PKDL treatment, and HIVco-infection (described in their Additional file 1: Figure S4). The sandfly population is modeled using an SEI
(Susceptible-Latent-Infectious) model. Treatment of VL
is divided into first and second-line treatment, and treatment-induced mortality caused by drug-toxicity is considered. The model was fit to data from the KalaNet trial
using Maximum Likelihood. The authors explored several intervention strategies, including treatment, active
case detection, and vector control. Although the authors
warn that their model assumes homogeneous transmission, ignoring possible clustering of cases within affected
households, their modeling approach and parameter estimation argues that the large asymptomatic reservoir precludes the ability for a treatment-only control program
to attain the desired target of less than 1 case per 10,000
individuals annually. Vector-based control is much more
promising, but the authors estimate it can only reasonably reduce VL incidence to 18.8 cases per 10,000. Consequently, the authors emphasize the need for active case
detection, effective treatment of PKDL, and vector control to achieve VL elimination.
Based on the model in Stauch et al. [51], and following up on their finding that treatment of VL does little to reduce transmission, Stauch et al. investigated the
uncertainty in their parameter estimates and explored
the efficacy of different vector-based control measures
[53]. They estimated that R0 for VL is approximately 4.71
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in India and Nepal, and that reducing the sandfly population by 79% via reduction of breeding sites, or reducing
the sandfly population by 67% through increasing sandfly mortality, are both sufficient to eliminate the L. donovani parasite in the human population. The authors argue
that recent evaluations of IRS (indoor residual spraying)
efficacy suggest that elimination should be possible, with
the caveat that the situation may change if insecticide
resistance emerges. However, vector management using
LLIN’s (long-lasting insecticide-treated nets) or EVM
(environmental management) would not be sufficient to
achieve elimination. The authors emphasize the need to
study infection rates, the parasite dynamics in both the
human and vector population, animals serving as alternate hosts or potentially infectious reservoirs, and the
contribution of the asymptomatic population. Furthermore, Stauch et al. suggest extensions of the deterministic modeling framework to include heterogeneity in
population and seasonality.
Stauch et al. [52] extended the model from their previous study [51] to include both drug-resistant and
drug-sensitive parasites. The authors considered five
mechanisms by which the fitness of the resistant strain
may differ from the sensitive strain: (1) increase probability of symptoms, (2) increase parasite load, (3) increase
infectivity of asymptomatic humans, (4) increase transmission from symptomatic and asymptomatic host to
vector, (5) increase transmission from vector to host.
Simulations of this extended model indicate that a treatment failure rate over 60% is required to explain observations in Bihar. Furthermore, observations in Bihar cannot
be explained without assuming an increase in fitness in
resistant parasites. The authors explain that it is more
likely that the necessary additional fitness is transmission-related rather than disease-related. Unfortunately,
their results also suggest that once a more fit resistant
parasite has been introduced, that parasite will eventually exclude the sensitive parasite, even in the absence of
treatment.
The work of Mubayi et al. is the first to use a rigorous,
and dynamic model to estimate underreporting of VL
cases at the district level in Bihar, India [3]. The authors
designed a staged-progression model, composed of a
system of nonlinear, coupled, ordinary differential equations. In a typical SIR type epidemic model, the inbuilt
assumption is that an individual stay in each infection
category for an exponentially distributed waiting time.
The stage-progression model considers a series of same
infection category (for examples, I1 , I2 , . . . , In for infectious category I), each with same average waiting rate.
It exploits the fact that the sum of n independent exponential distributions with rate parameter  is a gamma
distribution with shape parameter n and scale parameter
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1/ (Ŵ(n, 1/)), which helps in capturing the observed
variability in waiting time in a epidemiological category
such as incubation period, infectious period, and treatment duration. Furthermore, the authors address the differences between public and private health care facilities
in their treatment and reporting practices by assuming a
fraction of infected individuals p seek treatment in public health care facilities, and the remaining proportion
seek treatment in private clinics. Building an empirical
distribution for this parameter p and deriving a relationship between model parameters and monthly reported
incidence data allowed the authors to estimate the degree
of underreporting for each district for the years 2003 and
2005. This model analysis informed by incidence data
revealed that districts previously designated as low-risk
areas for VL are actually likely to be high-risk: the true
burden masked by underreporting.
ELmojtaba et al. presented a more classical approach to
modeling VL, with a focus on Sudan, in [54–56]. Because
leishmaniasis in the Sudan is zoonotic, the authors
included the dynamics of an animal (rodents and dogs)
reservoir in [54]. This baseline model is extended in [55]
to address parasite diversity, and in [56] to explore the
potential impact of mass vaccination in the presence of
immigration.
More recently, Sevá et al. [57] developed a mathematical model for human and canine zoonotic VL in Brazil.
The focus of this study was to test the efficacy of existing canine-based VL prevention and control methods:
insecticide-impregnated dog collars, culling, and vaccination. By optimizing each of these control strategies in
an ordinary differential equation model, while accounting
for their respective costs, the authors were able to recommend a 90% coverage of the dog population with insecticide-impregnated collars as a control strategy that is easy
to adopt and could, over time, eliminate VL in the region.
All of these modeling efforts (summarized in Table 1)
have either contributed to our understanding of VL or
highlighted the need for better data to construct and validate future models of VL. However, there are currently
no models, to the best of our knowledge, that attempt to
link socio-economic factors, like the 6 A’s discussed in
“Identified VL risk factors: challenges for leishmaniasis
transmission dynamics in resource-limited regions” section, to VL disease transmission.
Models of infectious diseases incorporating
socio‑economic risk factors

In this section, we provide some examples of published mathematical modeling studies (summarized in
Table 1) where researchers have attempted to incorporate some of the factors mentioned above and studied
their role in the transmission dynamics of infectious
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and physiological diseases. Existing models of visceral
leishmaniasis, though limited in number as compared
to diseases like malaria and dengue, have incorporated
some of the biological complexity, contributing to a more
developed understanding of the disease. However, to
formulate applicable control measure recommendations
with cost-estimation, models which can simultaneously
incorporate the discussed risk-factors explicitly would be
necessary. Many of the techniques to incorporate these
factors individually can be drawn from the literature
regarding heavily studied diseases like HIV, malaria, and
tuberculosis [58–60].
Modeling atmosphere

In a simplistic mathematical model we can incorporate
several risk factors associated with ambience implicitly
through the interpretation and calculation of the model
parameters. For example, the transmission parameter
can be considered as a product of the predominant type
of housing, density of vegetation around houses, number
of domesticated animals, and number of inhabitants in a
house [58].
Modeling adherence

Lipsitch et al. addressed adherence to treatment and
its role in promoting drug resistance in a mathematical model for tuberculosis (TB) in the presence of bacterial heterogeneity [59]. To model non-compliance to
drug therapy, the authors assumed that non-compliant
patients adhere to the treatment regimen when bacterial
loads are above a certain threshold, and will halt treatment when bacterial loads fall below this threshold, that
is,
 αB(t)
if B(t) ≥ Nmin
Adherence_level(t) = K +B(t)
0
if B(t) < Nmin
where B(t) is the bacterial load at time t and Nmin is the
threshold minimum bacterial load under which drug
treatment is discontinued. The parameter K is critical
bacterial load where adherence will become one-half
and α is the rate at which the individual adhere to treatment per unit of bacterial load. Simulation and analysis
of their stochastic-deterministic hybrid model illustrated
that non-compliance is one mechanism that can give
rise to bacteria resistant to one or more drugs in a multidrug therapy. Furthermore, the authors noted that the
pattern of resistance driven by non-compliance more
closely resembled observations of patients on multidrug therapy, compared with the pattern of resistance
promoted by bacterial heterogeneity. Consequently, the
model suggests that non-compliance plays a larger role
than heterogeneity of the bacteria population in promoting resistance during multi-drug therapy. The authors
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Table 1 Modeling studies, included in the review, that considers local risk factors and the transmission dynamics of diseases
Reference

Study area (period)

Disease

Data

Model type

6 A’s Addressed

Dye [47]

Assam Province, India
(1875–1950)

Anthroponotic VL (L.
donovani)

Epidemic data from Rogers
(1908) [69], McCombie
Young (1924) [70], and Sen
Gupta (1951) [71]

Discrete-time compartmental model

×

Hasibeder [48]

×

Canine leishmaniasis, L.
infantum

×

ODEs

×

Dye [49]

Gozo island in Malta
(June–July 1989)

Canine leishmaniasis, L.
infantum

cross-sectional survey includ- Used results from
ing age-structured serologiODEs in [48]
cal data

×

Dye [50]

Tropical America, Mediter- Canine and human
ranean, and China
zoonotic VL, L. infantum

Cohort study of dogs
ODEs
(Unpublished data, Quinell
RJ, Courtenay O, and Dye C)
and estimates from [49]

×

Stauch [51]

India, Nepal, Bangladesh
(2006–2008)

Anthroponotic VL - L.
donovani

KalaNet project
(ClinicalTrials,gov
NCT00318721)

ODEs

×

Stauch [52]

Bihar, India (1980–1997)

anthroponotic VL

Treatment failure rate of antimonial treatment obtained
from review of clinical trials
[72]

ODEs

×

Stauch [53]

India, Nepal, Bangladesh
(2006–2008)

Anthroponotic VL

KalaNet project

ODEs

×

Mubayi [3]

Bihar, India (2003–2005)

Anthroponotic VL

Monthly incidence from 21
districts

Staged-progression
model

×

ELmojtaba [54–56]

Sudan

Zoonotic VL

Parameter estimates from
literature

ODE

×

Sevá [57]

Brazil (approx. 1990s and
2000s)

Canine and human
zoonotic VL, L. infantum

Parameters taken from published studies, oral communication, or assumed

ODEs

×

Aparicio [58]

United States

TB

U.S. and Massachusetts
Census data and Parameter
estimates from literature

ODEs and an agestructured PDE
model

Atmosphere

Stochastic-deterministic hybrid model

Adherence

Discounted Markov
Decision Process

Adherence

Lipsitch [59]

TB

Mason [61]

United States (approx.
1995–2004)

Type II diabetes

Electronic Medical Records,
Administrative medical and
pharmacy claims data, and
Healthcare Effectiveness
Data

Hallet [62]

Zimbabwe (1980s–2000s)

HIV

HIV prevalence and sexual
ODEs and a Bayesian Awareness
behaviour surveillance data
Melding framework

Mushayabasa [63]

×

Hepatitis C

Epidemiological data from
literature

Fenichel [64]

ODEs

Awareness

Economic behavioral
model/SIR

Awareness

x in the Table indicate absence of the information related to column heading

noted that an exception to this pattern occurred in
HIV-positive TB patients. The modeling assumption for
non-compliance in this TB model addresses one of the
‘adherence’ concerns discussed in “Identified VL risk factors: challenges for leishmaniasis transmission dynamics
in resource-limited regions” section, namely that patients
often stop treatment once symptoms are relieved, suggesting a possible framework in which to study adherence

to treatment, treatment failure, and if tied to a population-level model, the spread of drug resistant parasites in
VL-endemic regions.
Adherence to treatment is also a concern in diabetes
patients, despite the fact that non-adherence increases
the likelihood for stroke and other potentially fatal complications. Mason et al. [61] developed a Markov Decision
process (MDP) model to study the timing of treatment
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initiation and drug-adherence in diabetes patients and the
role these two factors play in determining a patients’ qualityadjusted life years (QALYs). Consistent with observations of
adherence behavior in diabetes patients, the model assumed
that a patient’s health status does not influence future
adherence. This assumption may be relevant for some VLendemic regions where non-adherence is a consequence
of insufficient inculcation of the risks associated with
improper treatment, or a result of the cost of treatment. The
model also assumed, consistent with clinical practice, that if
a patient or the patient’s physician had not already decided
to begin treatment, treatment would be immediately initiated following a non-fatal complication. The reward function, dependent on adherence, included several important
factors, including QALY, the cost of treatment and hospitalization, and disutility resulting from treatment side effects.
The authors also developed a cost function, with the goal of
optimizing treatment initiation, in the presence of different
degrees of non-adherence, and compared the optimal timing for ‘uncertain adherence’ and ‘predictable adherers’. The
authors quantified the benefit of treatment relative to the
cost through a reward function rt (l, m), where l denoted the
patient’s health status, and m equaled zero or one, depending on whether the patient was on treatment or not.

rt (l, m) = R(l, m) − Ct0 − (CF S (l) + CF CHD (l))
− mC ST (A) − (C S (l) + C CHD (l)),
for t = 1, . . . , T − 1, l ∈ L, m ∈ M, where

R(l, m) = R0 (d S (l))(d CHD (l))(md ST (A)),
l ∈ L, m ∈ M
describes the reward for 1 quality-adjusted life. The decrement factors d S , d CHD , and d ST denote the decrease in quality of life from a stroke (S), a coronary heart disease (CHD)
event, or statins initiation (SI), respectively. The costs
C O , C ST , C S and C CHD, and C FS and CF CHD represent the
cost of other health care for diabetes patients, cost of statin treatment, cost of initial hospitalization for stroke and
CHD events, and cost of follow-up treatment for stroke and
CHD events, respectively. This diabetes model suggested
that initiation of treatment should be delayed in individuals predicted to have poor future adherence. Furthermore,
the model predicted that over time, only 25% of patients will
remain adherers for greater than 80% of the days during the
study.
Modeling awareness

The effect of change in disease dynamics due to behavioral change and educational awareness have been modeled using ordinary differential equations-based models
in several studies. Hallett et al. analyzed the effect of
behavior change on the course of an HIV epidemic [62].
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In their dynamic model, the behavior is incorporated
by considering parameters such as mean rate of partner change and condom use in casual relationship as a
step-function depending on time at which the change in
behavior occurred and time it takes to reach a new value.
In Mushayabasa et al., an ordinary differential equation
model was used to quantify the role of an educational
campaign in controlling Hepatitis C among women in
prison [63]. Here, the effect of this campaign is reflected
as an efficacy factor in conjunction to the parameters
which represent the sharing of contaminated needles or
syringes among the susceptible and exposed classes.
Ideas for VL modeling should also draw from modeling
techniques used in economics in the context of social
sciences to effectively optimize the cost and strategy in
a resource-limited region. Fenichel et al. used an economic behavioral model in conjunction with the classical
Susceptible-Infected-Recovered (SIR) model that explicitly models adaptive contact behavior [64]. The authors
construct a utility function, an index which describes
an individual’s well-being. The framework assumes that
individuals make choices that maximize their utility.
These decisions then impact disease risk, creating a feedback loop between disease risk and decisions made based
on perceived disease risk. The authors demonstrate that
fitting the classical SIR model to data generated by their
new framework results in erroneous estimates of epidemiological parameters, because of its inability to jointly
estimate behavioral and biological parameters. See Perrings et al. for a thorough review on the growing topic of
economic epidemiology [65].
Bridging the gap

The results of models addressing adherence to treatment, adaptive human behavior, and resource constraints
emphasize the need to bridge the gap between socioeconomic factors and existing mathematical modeling
frameworks. Models of other vector borne diseases have
captured some of the critical factors for visceral leishmaniasis (“Models of infectious diseases incorporating
socio-economic risk actors” section). However, there is
need for a more comprehensive set of frameworks that
can incorporate local VL risk factors at multiple scales
in the same dynamical model. The 6 A’s should be systematically incorporated into VL model frameworks to
assess the sensitivity of VL dynamics to these six socioeconomic factors. A schematic diagram depicting one
such inter-dependent modeling framework is given in
Fig. 3. Failing to address factors that result in significant
changes in disease dynamics may result in models that
do not effectively inform public health policy. Likewise,
models that do not acknowledge resource constraints
may lead to infeasible control policies.
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Fig. 3 Caricature of critical categories of modeling frameworks for studying dynamics of vector-borne diseases (green rhombus), types of data
needed in such frameworks (orange oval) and their potential links (red arrow). SV and IV represent densities of susceptible and infectious vectors. SH
, AH, IH and RH are human epidemiological stages representing susceptible, asymptomatic, infectious, and recovered stages. 1st and 2nd line are for
types of treatments whereas DAT and rk39 are for diagnostic methods. Light green box represents the output from respective modeling frameworks.
These frameworks are mere examples in each categories and hence, each one of them can incorporate more details depending on the goals

Discussion
NTDs, including VL, continue to spread in almost
every continent on the planet, particularly in the poorest regions of modern human civilization [66, 67]. The
campaign to eliminate VL from the Indian sub-continent,
endorsed by the WHO, were set twice in the past (2010
and 2015) but target goals were not met [10]. The reasons for the ongoing spread and failure to control VL are
thought to be mainly contributed by underreporting of
cases [3], poor infrastructure, lack of awareness, poverty
and inadequate control measures. In this review we have
presented some of the less highlighted, but nonetheless
critical factors/mechanisms, which are key in one of the
worst VL affected impoverished regions, especially in
the Indian state of Bihar. These factors may also play an
important role in the transmission of other NTDs [3].
Mathematical models have been used to understand
transmission dynamics of other tropical infections and
strategize control measures under relevant constraints
with varied success. Moreover, recent development of

effective modeling techniques for infectious diseases,
new sophisticated parameterizations methods [68] and
useful validation tools have provided significant assistance to decision makers. However, modeling based
study for evaluating temporal policies for NTDs are
either limited or use risk factors that are known for
well studied diseases. We suggest novel critical risk
factors needed for effectively studying long term policies for NTDs and requires a rethinking of the manner in which address regional issues. There is a need
for more modeling-based studies for NTDs, including
for VL, that comprehensively address the six risk factors identified in this manuscript: Atmosphere, Access,
Availability, Awareness, Adherence, and Accedence.
Models that incorporate diverse local conditions as
shown in Fig. 3 will allow formulation of effective public health strategies which will alleviate the burden
of VL in under-developed regions like Bihar with it’s
resource constraints. Thus, we propose mathematical
modeling as an efficient and cost-effective tool to devise
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meaningful control measures that will make the next
WHO leishmaniasis elimination goal successful. Modeling studies are heavily dependent on the availability
of region-specific surveillance, entomological and ecological data, and maintenance of a such database is also
important for these regions where large scale integrated
control programs are being introduced to achieve
elimination.
In light of the major financial constraints in the affected
regions, a hybrid dynamic optimization model (an example framework is shown in Fig. 3) will be necessary to
explicitly calculate monetary (cost of interventions) and
non-monetary (mortality and morbidity) factors related
to VL. The building of such a model will require detailed
quantification of every aspect of life in the regions,
including non-tangible issues discussed here. Moreover,
the execution of this model will require extensive sets of
data on these varied aspects, which is challenging considering the current dearth of data. This will elucidate our
understanding of the magnitude of this problem and estimate the relative importance of different socio-economic
factors; thus, accurately predicting disease dynamics and
informing effective public health policies.
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